In this study, we examined the expression and subcellular localization pattern of TMEM88 in tissues obtained from 64 triple-negative breast cancer and 75 non-triple-negative breast cancer (ER-, PR-, and Her2- positive expression; hereafter referred to as triple-positive breast cancer, TPBC) patients. Here, TMEM88 is linked to triple-negative breast carcinoma.